Little blue pill: Big Pharma is pushing for a cheaper version of the drug that will treat weight gain and diabetes, says a report

Business Insider has the story. 

Little blue pill, also known as Ritalin, is one of the best-selling drugs in the world.

It has helped millions of people get their life back on track.

But the drug is also causing problems for people with diabetes. 

 “If you take it, the drug just kills you,” said Dr. Michael Balsamo, a medical doctor at New York University School of Medicine. 

“And the drug itself, it kills you, the insulin levels go down, and the body gets tired and it doesn’t get enough energy.” 

The problem is that the drug doesn’t work like a insulin pump, which is why doctors are looking to other ways to treat diabetes.

For example, the pills work by stimulating your body’s own fat cells to burn more fat. 

It can help with weight loss.

But it can also cause side effects.

Balsamos side effects are pretty common.

“I have a couple of patients who are having severe side effects, but it is very uncommon,” he said. 

But Balsamico thinks the drug could help prevent diabetes in people with metabolic syndrome.

Balsamo has been working on ways to create a cheaper generic version of Ritalins pill. 

His company, Little Blue Pill, has been testing it in people in the U.S. and abroad for a few years.

The company plans to launch a generic version by the end of the year.

The drug was approved in 2012 for treating obesity and metabolic syndrome in the United States, but Balsaminos hopes to start selling it in the future. 

There are about 10 million people in America who have metabolic syndrome, according to the CDC.

And about one in six people will have metabolic disorder, according the Centers for Disease Control and Prevention.

Blesamico said he thinks the new drug could have a big impact on people with the condition.

“People who are metabolically impaired are more likely to develop obesity,” he told Business Insider. 

The new drug would also reduce the risk of diabetes.

It would take a small pill, like a 10 mg tablet, to help people with moderate-to-severe obesity. 

However, Balsams side effects can still happen, so people with severe metabolic syndrome will have to take more than one pill a day. 

For people with more severe cases of metabolic syndrome like obesity and diabetes it can be difficult to avoid the side effects Balsamonos has seen. 

Balsamicos said the pill is being tested in patients in Brazil.

The first phase of testing in Brazil started last month and has now taken place in a small number of people.

In Brazil, it is also being tested on people over age 40, with the results expected this summer. 

In a blog post on the company’s website, Blesamos said Little Blue pill is designed to work with people who are overweight or obese, and that it is available to people in their 30s and 40s. 

Other drug companies are testing the pill, too. 

Cancer drug makers are testing an insulin pump for people who need to control blood sugar levels. 

Pepcion, another insulin pump manufacturer, is testing a generic variant of RIT as part of its diabetes research. 

Big Pharma is testing an injection called the RIT insulin pump in people who have diabetes and who have not previously been diagnosed. 

These insulin pumps are already being used in the US for people that are overweight. 

Insulin pumps that can help people control their blood sugar have been around for years, but are still not available to the general public.

Insulin pills are used in some areas of the US as a way to help control blood sugars and people who struggle to control their weight. 

Healthier pills may be used for people diagnosed with metabolic disorders like obesity.

But Balsamios said this could not happen for people without metabolic disorders. 

He said the new pill could help people living with metabolic disorder get the drugs they need to live normal lives.

“You don’t have to be diabetic to use a pill,” Balsamy said.

“There are so many people who can get these pills.” 

For more information on the new Ritalini, visit the company website at: